Osaic Holdings’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,045
| Closed | -$35.1K | – | 8125 |
|
|
2025
Q3 | $35.1K | Sell |
4,045
-138
| -3% | -$1.24K | ﹤0.01% | 5542 |
|
|
2025
Q2 | $38.1K | Buy |
4,183
+16
| +0.4% | +$118 | ﹤0.01% | 5239 |
|
|
2025
Q1 | $33.1K | Buy |
4,167
+3,861
| +1,262% | +$28.3K | ﹤0.01% | 5006 |
|
|
2024
Q4 | $1.66K | Buy |
306
+75
| +32% | +$459 | ﹤0.01% | 6679 |
|
|
2024
Q3 | $1.67K | Sell |
231
-436
| -65% | -$3.99K | ﹤0.01% | 6680 |
|
|
2024
Q2 | $7.24K | Sell |
667
-5,715
| -90% | -$73.2K | ﹤0.01% | 5988 |
|
|
2024
Q1 | $120K | Buy |
6,382
+278
| +5% | +$6.41K | ﹤0.01% | 4115 |
|
|
2023
Q4 | $132K | Sell |
6,104
-6,025
| -50% | -$119K | ﹤0.01% | 4228 |
|
|
2023
Q3 | $250K | Buy |
12,129
+2,289
| +23% | +$66.1K | ﹤0.01% | 3833 |
|
|
2023
Q2 | $463K | Sell |
9,840
-3,520
| -26% | -$175K | ﹤0.01% | 3209 |
|
|
2023
Q1 | $561K | Sell |
13,360
-463
| -3% | -$19.9K | ﹤0.01% | 2999 |
|
|
2022
Q4 | $528K | Buy |
13,823
+150
| +1% | +$5.73K | ﹤0.01% | 2971 |
|
|
2022
Q3 | $536K | Sell |
13,673
-141
| -1% | -$5.45K | ﹤0.01% | 2837 |
|
|
2022
Q2 | $447K | Buy |
13,814
+2,408
| +21% | +$80.7K | ﹤0.01% | 3043 |
|
|
2022
Q1 | $378K | Buy |
11,406
+4,432
| +64% | +$167K | ﹤0.01% | 3488 |
|
|
2021
Q4 | $296K | Buy |
6,974
+4,444
| +176% | +$186K | ﹤0.01% | 3578 |
|
|
2021
Q3 | $111K | Sell |
2,530
-6,681
| -73% | -$306K | ﹤0.01% | 4436 |
|
|
2021
Q2 | $527K | Buy |
9,211
+8,244
| +853% | +$583K | ﹤0.01% | 2982 |
|
|
2021
Q1 | $73K | Sell |
967
-174
| -15% | -$14.3K | ﹤0.01% | 4596 |
|
|
2020
Q4 | $99K | Buy |
1,141
+625
| +121% | +$46.1K | ﹤0.01% | 4051 |
|
|
2020
Q3 | $31K | Sell |
516
-282
| -35% | -$14.3K | ﹤0.01% | 4649 |
|
|
2020
Q2 | $32K | Sell |
798
-95
| -11% | -$3.45K | ﹤0.01% | 4505 |
|
|
2020
Q1 | $25K | Buy |
+893
| New | +$51.7K | ﹤0.01% | 4480 |
|
Other funds holding SAGE
Osaic Holdings's SAGE Position: Q4 2025 in Review
Osaic Holdings sold out of Sage Therapeutics (SAGE) in Q4 2025, closing a stake of 4,045 shares — an estimated $35.1K sold.
Osaic Holdings first reported a position in SAGE in Q1 2020 and held it in 23 quarters. The position peaked at $561K in Q1 2023. 2 funds tracked by Wall St. Rank hold SAGE as of Q4 2025.
- Osaic Holdings reported no remaining Sage Therapeutics position as of Q4 2025 after selling out during the quarter.
- Osaic Holdings sold 4,045 Sage Therapeutics shares in Q4 2025, an estimated $35.1K.
- Osaic Holdings first reported a position in Sage Therapeutics in Q1 2020 and held it in 23 quarters.
- Osaic Holdings's Sage Therapeutics position peaked at $561K in Q1 2023.
- 2 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2025.
Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.